|
|
|
|
Vol. 53, Issue 4, 613-622, April 1998

Dimer-Mediated Pathway Contributes to
Mitogen-Activated Protein Kinase Activation by Thyrotropin-Releasing
Hormone Receptors in Transfected COS-7 Cells
Departamento de Bioquímica y Biología Molecular,
Facultad de Medicina, Universidad de Oviedo, E-33006, Oviedo, Spain
Activation of mitogen-activated protein kinase (MAPK) is induced by
adding thyrotropin-releasing hormone (TRH) to COS-7 cells cotransfected
with TRH receptors and an epitope-tagged MAPK. Long term treatment of
the cells with pertussis toxin has no effect on TRH-induced MAPK
activation. Incubation of the cells with the protein kinase C (PKC)
inhibitor GF109203X causes an almost complete inhibition of MAPK
activation by the PKC activator phorbol-12-myristate-13-acetate. In
contrast, only ~50% of the TRH-induced MAPK activity is inhibited by
GF109203X, indicating that activation of MAPK by TRH is only partially
dependent on PKC. The inhibitory effect of GF109203X is additive with
that of p21N17ras, a dominant negative mutant of
p21ras that exerts little effect on PKC-dependent MAPK
activation by phorbol-12-myristate-13-acetate. The TRH-induced
activation of MAPK also is inhibited partially by overexpression of
transducin
subunits (
t), an agent known to sequester free G
protein 
dimers. However, the inhibitory potency of
t on
TRH-induced activation is about half of that obtained in cells
transfected with m2 muscarinic receptors, which activate MAPK
exclusively through 
dimers. The effect of
t is also additive
with that of GF109203X but not with that of p21N17ras. MAPK
activation is not induced by the constitutively active form of
G
q due to an inhibitory effect of its expression at a
step downstream of that at which PKC-dependent and -independent routes
to MAPK converge. Our results demonstrate that TRH receptors activate
MAPK by a pathway only partially dependent on PKC activity. Furthermore, they indicate that 
dimers of a pertussis and
cholera toxin-insensitive G protein are involved in the PKC-independent fraction of the dual signaling route to MAPK initiated in the TRH
receptor.
This article has been cited by other articles:
![]() |
L. Luo, N. Yano, and J. Z. Q. Luo The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E889 - E899. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Miranda, T. Giraldez, P. de la Pena, D. G Manso, C. Alonso-Ron, D. Gomez-Varela, P. Dominguez, and F. Barros Specificity of TRH receptor coupling to G-proteins for regulation of ERG K+ channels in GH3 rat anterior pituitary cells J. Physiol., August 1, 2005; 566(3): 717 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gomez-Varela, T. Giraldez, P. d. la Pena, S. G Dupuy, D. Garcia-Manso, and F. Barros Protein kinase C is necessary for recovery from the thyrotropin-releasing hormone-induced r-ERG current reduction in GH3 rat anterior pituitary cells J. Physiol., March 15, 2003; 547(3): 913 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Galas, M.-C. Tonon, D. Beaujean, R. Fredriksson, D. Larhammar, I. Lihrmann, S. Jegou, A. Fournier, N. Chartrel, and H. Vaudry Neuropeptide Y Inhibits Spontaneous {alpha}-Melanocyte-Stimulating Hormone ({alpha}-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced {alpha}-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells Endocrinology, May 1, 2002; 143(5): 1686 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect? Endocrinology, March 1, 2002; 143(3): 744 - 746. [Full Text] [PDF] |
||||
![]() |
J. Smith, R. Yu, and P. M. Hinkle Activation of MAPK by TRH Requires Clathrin-Dependent Endocytosis and PKC but Not Receptor Interaction with {beta}-Arrestin or Receptor Endocytosis Mol. Endocrinol., September 1, 2001; 15(9): 1539 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grosse, S. Roelle, A. Herrlich, J. Hohn, and T. Gudermann Epidermal Growth Factor Receptor Tyrosine Kinase Mediates Ras Activation by Gonadotropin-releasing Hormone J. Biol. Chem., April 14, 2000; 275(16): 12251 - 12260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Call and M. W. Wolfe Gonadotropin-Releasing Hormone Activates the Equine Luteinizing Hormone {beta} Promoter Through a Protein Kinase C/Mitogen-Activated Protein Kinase Pathway Biol Reprod, September 1, 1999; 61(3): 715 - 723. [Abstract] [Full Text] |
||||
![]() |
L. Galas, M. Lamacz, M. Garnier, E. W. Roubos, M.-C. Tonon, and H. Vaudry Involvement of Protein Kinase C and Protein Tyrosine Kinase in Thyrotropin-Releasing Hormone-Induced Stimulation of {alpha}-Melanocyte-Stimulating Hormone Secretion in Frog Melanotrope Cells Endocrinology, July 1, 1999; 140(7): 3264 - 3272. [Abstract] [Full Text] |
||||
![]() |
C. W. Emala, F. Liu, and C. A. Hirshman Gialpha but not Gqalpha is linked to activation of p21ras in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L564 - L570. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Budd, G. B. Willars, J. E. McDonald, and A. B. Tobin Phosphorylation of the Gq/11-coupled M3-Muscarinic Receptor Is Involved in Receptor Activation of the ERK-1/2 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., February 9, 2001; 276(7): 4581 - 4587. [Abstract] [Full Text] [PDF] |
||||